ARCHIVES

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: WHI Revises Protocol After Study Finds High Rate Of Endometrial Hyperplasia

January 27, 1995

Dose Adjustments Of Other Drugs Questioned; Underdosing Or Overdosing?

October 15, 2010

ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent.

March 14, 2008

In Brief: Congress Corrects An Inequity; Califano Gets a Health Assistant – Fordham Of N.C.

March 25, 1977

DCT Board Restores Funding to Rosenberg’s Lymphocyte Projects

June 17, 1994

NCAB Subcommittee Works On Drafting Quantitative Risk Assessment Policy

October 1, 1982